These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29061818)

  • 1. The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines.
    Müller L; Radtke A; Decker J; Koch M; Belge G
    Anticancer Res; 2017 Nov; 37(11):6341-6345. PubMed ID: 29061818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
    Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
    Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
    Roberto D; Klotz LH; Venkateswaran V
    Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.
    Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
    Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.
    Xian XS; Park H; Choi MG; Park JM
    Anticancer Res; 2013 Jun; 33(6):2541-7. PubMed ID: 23749906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
    Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
    Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.
    Hong Y; Zhou Y; Wang Y; Xiao S; Liao DJ; Zhao Q
    Mol Biol Rep; 2013 Nov; 40(11):6287-93. PubMed ID: 24062073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor.
    Almada M; Costa L; Fonseca BM; Amaral C; Teixeira N; Correia-da-Silva G
    Toxicology; 2017 Jun; 385():67-73. PubMed ID: 28495606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines.
    Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells.
    Xian XS; Park H; Cho YK; Lee IS; Kim SW; Choi MG; Chung IS; Han KH; Park JM
    J Cell Biochem; 2010 May; 110(2):321-32. PubMed ID: 20336665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer.
    Oh JH; Lee JY; Baeg MK; Han KH; Choi MG; Park JM
    Chemotherapy; 2013; 59(3):200-6. PubMed ID: 24335109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
    Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
    Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.
    Aguirre-Rueda D; Guerra-Ojeda S; Aldasoro M; Iradi A; Obrador E; Mauricio MD; Vila JM; Marchio P; Valles SL
    PLoS One; 2015; 10(4):e0122843. PubMed ID: 25874692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
    Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
    J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
    Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
    Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.
    Ortega A; Rangel-López E; Hidalgo-Miranda A; Morales A; Ruiz-García E; Meneses-García A; Herrera-Gómez A; Aguilar-Ponce JL; González-Herrera IG; Guevara-Salazar P; Prospero-García O; Del Angel SA
    Toxicol In Vitro; 2015 Oct; 29(7):1941-51. PubMed ID: 26255146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.